In patients with risk factors or symptoms of thoracic aortic disease, early identification and management often provide for expanded treatment options and a reduction in acute events. The Aortic Center, a part of Baylor Scott & White The Heart Hospital – Plano’s Center for Advanced Cardiovascular Care, offers a comprehensive, proactive approach to diagnosing, monitoring and treating these conditions.
When arthritis and other conditions attack the hips, knees and other joints, exercise, hobbies – even a quick stroll across the house – can bring agony. For most patients, joint replacement is a life-changing experience, restoring normal range of motion and allowing a return to normal routines. And as the population ages, the number of replacement surgeries is on the rise.
Over the past several years, focused research efforts have led to innovative surgical and transcatheter treatment options for aortic and mitral valve diseases. Now, these same efforts are on the rise in another area – the tricuspid valve – with the hope of achieving similar advantages and outcomes for patients.
Baylor Scott & White The Heart Hospital – Plano is one of a few centers in the region currently offering fenestrated stent grafts for endovascular abdominal aortic aneurysm (AAA) repair. When there is not enough room between the renal arteries and the AAA for a standard endovascular graft to function properly, a fenestrated stent graft may provide another option.
Cardiologists on the medical staff at Baylor Scott & White The Heart Hospital – Plano are now using the first and only leadless pacemaker in the United States as a treatment option for patients with bradycardia. The Micra™ transcatheter pacing system (TPS) is about the size of a multivitamin, making it 93 percent smaller than traditional devices and the world’s smallest pacemaker.
